srch

Blueprint Medicines contends a small molecule from Lengo Therapeutics has advantages over two newly approved targeted therapies from two big ...

Blueprint Medicines is a precision therapy company that invents life-changing medicines for cancer and hematologic disorders.

1 dag siden · About Blueprint Medicines Blueprint Medicines is a global precision therapy company that invents life-changing therapies for people with cancer and hematologic disorders. Applying an approach that...

15.12.2021 · Blueprint anticipates the acquisition will close in the fourth quarter of 2021. Lengo Therapeutics, founded in 2019, is a biopharmaceutical company committed to developing novel, small molecule precision therapeutics that target so-call “driver mutations” in oncology.

29.11.2021 · cambridge, mass. and san diego, nov. 29, 2021 /prnewswire/ -- blueprint medicines corporation (nasdaq: bpmc) today announced that the company has entered into a definitive agreement under which it...

Our uniquely targeted, scalable approach empowers the rapid design and development of new precision therapies as we aim to stay one step ahead of disease. Our ...

30.12.2021 · About Blueprint Medicines Blueprint Medicines is a global precision therapy company that invents life-changing therapies for people with cancer and hematologic disorders. Applying an approach that...

Applying an approach that is both precise and agile, we create therapies that selectively target genetic drivers, with the goal of staying one step ahead ...

30.11.2021 · Blueprint Medicines Corporation ( BPMC Quick Quote BPMC - Free Report) announced a definitive agreement to acquire San Diego, CA-based privately held biopharmaceutical company, Lengo Therapeutics,...

1 dag siden · About Blueprint Medicines Blueprint Medicines is a global precision therapy company that invents life-changing therapies for people with cancer and hematologic disorders. Applying an approach that...

The Blueprint Neurotherapeutics Network provides non-dilutive support for small molecule drug discovery and development, from hit-to-lead chemistry through ...

Investment company Boxer Capital, Llc (Current Portfolio) buys Tyra Biosciences Inc, Tango Therapeutics Inc, Blueprint Medicines Corp, Fulcrum Therapeutics Inc, ...

1 dag siden · About Blueprint Medicines Blueprint Medicines is a global precision therapy company that invents life-changing therapies for people with cancer and hematologic disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease.

NEW YORK – Blueprint Medicines on Monday said it will acquire San Diego-based Lengo Therapeutics in a deal worth up to $465 million in a bid ...

19 rader · 01.12.2021 · Blueprint Medicines and Roche have co-exclusive rights to develop and …

1 dag siden · About Blueprint Medicines Blueprint Medicines is a global precision therapy company that invents life-changing therapies for people with cancer and hematologic disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease.

Blueprint Medicines Precision that moves Our uniquely targeted, scalable approach empowers the rapid design and development of new precision therapies as we aim to stay one step ahead of disease. Our platform The tweet could not be loaded. It could have been blocked by your browser's settings.